{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:54:57Z","timestamp":1778324097797,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jconrel.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T22:02:41Z","timestamp":1613599361000},"page":"636-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Targeted delivery of mycophenolic acid to the mesenteric lymph node using a triglyceride mimetic prodrug approach enhances gut-specific immunomodulation in mice"],"prefix":"10.1016","volume":"332","author":[{"given":"Ruby","family":"Kochappan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enyuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sifei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luojuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Quach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Senyschyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilena Ivanova","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Given","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathania","family":"Leong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shea Fern","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron J.","family":"Nowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich H.","family":"von Andrian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine D.","family":"Mintern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie S.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie L.","family":"Trevaskis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.H.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jconrel.2021.02.008_bb0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cell.2020.06.039","article-title":"The lymphatic vasculature in the 21st century: novel functional roles in homeostasis and disease","volume":"182","author":"Oliver","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.02.008_bb0010","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1126\/science.aax4063","article-title":"Biological functions of lymphatic vessels","volume":"369","author":"Petrova","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2021.02.008_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.addr.2017.07.005","article-title":"Exploiting lymphatic vessels for immunomodulation: rationale, opportunities, and challenges","volume":"114","author":"Maisel","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2021.02.008_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev-bioeng-112315-031200","article-title":"The lymphatic system in disease processes and Cancer progression","volume":"18","author":"Padera","year":"2016","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.jconrel.2021.02.008_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20171868","article-title":"Organ-specific lymphatic vasculature: from development to pathophysiology","volume":"215","author":"Petrova","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2021.02.008_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-immunol-041015-055354","article-title":"The lymphatic system: integral roles in immunity","volume":"35","author":"Randolph","year":"2017","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2021.02.008_bb0035","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.jconrel.2021.02.008_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2249.2012.04602.x","article-title":"Lymph node dissection--understanding the immunological function of lymph nodes","volume":"169","author":"Buettner","year":"2012","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.jconrel.2021.02.008_bb0045","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/intimm\/dxn110","article-title":"The conduit system of the lymph node","volume":"20","author":"Roozendaal","year":"2008","journal-title":"Int. Immunol."},{"issue":"8","key":"10.1016\/j.jconrel.2021.02.008_bb0050","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.it.2007.06.005","article-title":"Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node","volume":"28","author":"Bajenoff","year":"2007","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2021.02.008_bb0055","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3298","article-title":"HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes","volume":"12","author":"Girard","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.02.008_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-065X.1997.tb00955.x","article-title":"Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex","volume":"156","author":"Gretz","year":"1997","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2021.02.008_bb0065","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.celrep.2016.04.007","article-title":"Targeted delivery of immunomodulators to lymph nodes","volume":"15","author":"Azzi","year":"2016","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.jconrel.2021.02.008_bb0070","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1172\/JCI120923","article-title":"Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival","volume":"128","author":"Bahmani","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"28","key":"10.1016\/j.jconrel.2021.02.008_bb0075","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.1073\/pnas.1120611109","article-title":"Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis","volume":"109","author":"Yeste","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jconrel.2021.02.008_bb0080","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/nn405033r","article-title":"A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease","volume":"8","author":"Hunter","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.02.008_bb0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2014.04.051","article-title":"Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers","volume":"193","author":"Ryan","year":"2014","journal-title":"J. Control. Release"},{"issue":"47","key":"10.1016\/j.jconrel.2021.02.008_bb0090","doi-asserted-by":"crossref","first-page":"14467","DOI":"10.1073\/pnas.1508516112","article-title":"Engineering opportunities in cancer immunotherapy","volume":"112","author":"Jeanbart","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jconrel.2021.02.008_bb0095","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"Fletcher","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.jconrel.2021.02.008_bb0100","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"38","key":"10.1016\/j.jconrel.2021.02.008_bb0105","doi-asserted-by":"crossref","first-page":"15745","DOI":"10.1073\/pnas.1105200108","article-title":"In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles","volume":"108","author":"Jewell","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2021.02.008_bb0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pathophys.2009.09.003","article-title":"Gastrointestinal lymphatics in health and disease","volume":"17","author":"Alexander","year":"2010","journal-title":"Pathophysiology"},{"issue":"6","key":"10.1016\/j.jconrel.2021.02.008_bb0115","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.addr.2007.09.007","article-title":"Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update","volume":"60","author":"Trevaskis","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.02.008_bb0120","series-title":"Handbook of Physiology, The Cardiovascular System, Microcirculation","first-page":"449","article-title":"Lymphocyte trafficking comprehensive physiology","author":"Kogan","year":"2008"},{"issue":"3","key":"10.1016\/j.jconrel.2021.02.008_bb0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20052016","article-title":"Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells","volume":"203","author":"Worbs","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2021.02.008_bb0130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.med.48.1.341","article-title":"Oral tolerance for the treatment of autoimmune diseases","volume":"48","author":"Weiner","year":"1997","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2021.02.008_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00005-006-0001-7","article-title":"Treating autoimmune diseases through restoration of antigen-specific immune tolerance","volume":"54","author":"Wolfraim","year":"2006","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"9","key":"10.1016\/j.jconrel.2021.02.008_bb0140","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri2153","article-title":"Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease","volume":"7","author":"Miller","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.02.008_bb0145","first-page":"1","article-title":"Antigen-based immunotherapy for autoimmune disease: current status","volume":"4","author":"Hirsch","year":"2015","journal-title":"Immunotargets Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2021.02.008_bb0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.10.046","article-title":"Leukocyte trafficking to the small intestine and colon","volume":"150","author":"Habtezion","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jconrel.2021.02.008_bb0155","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1021\/mp100259a","article-title":"Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?","volume":"7","author":"Trevaskis","year":"2010","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2021.02.008_bb0160","doi-asserted-by":"crossref","first-page":"14542","DOI":"10.1038\/s41598-017-15026-z","article-title":"Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation","volume":"7","author":"Zgair","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.02.008_bb0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2018.07.022","article-title":"Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system","volume":"286","author":"Lee","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.02.008_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2013.12.031","article-title":"Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies","volume":"177","author":"Han","year":"2014","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.jconrel.2021.02.008_bb0175","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1021\/acs.molpharmaceut.6b00195","article-title":"Lymphatic transport and lymphocyte targeting of a triglyceride mimetic prodrug is enhanced in a large animal model: studies in greyhound dogs","volume":"13","author":"Han","year":"2016","journal-title":"Mol. Pharm."},{"issue":"16","key":"10.1016\/j.jconrel.2021.02.008_bb0180","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1073\/pnas.0901128106","article-title":"Transience of MHC class I-restricted antigen presentation after influenza a virus infection","volume":"106","author":"Mintern","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jconrel.2021.02.008_bb0185","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1440-1711.2000.00889.x","article-title":"Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection","volume":"78","author":"Clarke","year":"2000","journal-title":"Immunol. Cell Biol."},{"issue":"10","key":"10.1016\/j.jconrel.2021.02.008_bb0190","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"794","key":"10.1016\/j.jconrel.2021.02.008_bb0195","article-title":"Androgen-induced immunosuppression","volume":"9","author":"Gubbels Bupp","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.jconrel.2021.02.008_bb0200","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1007\/s11095-013-1000-0","article-title":"A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport","volume":"30","author":"Trevaskis","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.02.008_bb0205","first-page":"2259","article-title":"The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation","volume":"44","author":"Quah","year":"2010","journal-title":"J. Vis. Exp."},{"issue":"5","key":"10.1016\/j.jconrel.2021.02.008_bb0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1051\/mmnp\/20127505","article-title":"The use of CFSE-like dyes for measuring lymphocyte proliferation: experimental considerations and biological variables","volume":"7","author":"Quah","year":"2012","journal-title":"Math. Model. Nat. Phenom."},{"issue":"2","key":"10.1016\/j.jconrel.2021.02.008_bb0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-3083.1991.tb03747.x","article-title":"Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice","volume":"33","author":"Eugui","year":"1991","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2021.02.008_bb0220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00007691-200104000-00005","article-title":"Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid","volume":"23","author":"van Gelder","year":"2001","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.jconrel.2021.02.008_bb0225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.1552-4604.1996.tb04207.x","article-title":"Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration","volume":"36","author":"Bullingham","year":"1996","journal-title":"J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.jconrel.2021.02.008_bb0230","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.4049\/jimmunol.171.8.3928","article-title":"Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection","volume":"171","author":"De Boer","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2021.02.008_bb0235","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fphys.2020.00458","article-title":"Intestinal lymph flow, and lipid and drug transport scale Allometrically from pre-clinical species to humans","volume":"11","author":"Trevaskis","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2021.02.008_bb0240","series-title":"Prodrugs: Challenges and Rewards","author":"Stella","year":"2007"},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2021.02.008_bb0245","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0928-0987(00)00161-5","article-title":"Rationale and applications of lipids as prodrug carriers","volume":"11","author":"Lambert","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2021.02.008_bb0250","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1021\/acsnano.8b04315","article-title":"Oral nanoparticles exhibit specific high-efficiency intestinal uptake and lymphatic transport","volume":"12","author":"Kim","year":"2018","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.jconrel.2021.02.008_bb0255","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1007\/s11095-014-1579-9","article-title":"Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug","volume":"32","author":"Han","year":"2015","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2021.02.008_bb0260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0005-2760(86)90344-9","article-title":"Mouse preheparin plasma contains high levels of hepatic lipase with low affinity for heparin","volume":"878","author":"Peterson","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.jconrel.2021.02.008_bb0265","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.immuni.2007.06.007","article-title":"B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node","volume":"27","author":"Carrasco","year":"2007","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jconrel.2021.02.008_bb0270","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ni1494","article-title":"Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells","volume":"8","author":"Phan","year":"2007","journal-title":"Nat. Immunol."},{"issue":"7166","key":"10.1016\/j.jconrel.2021.02.008_bb0275","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06287","article-title":"Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells","volume":"450","author":"Junt","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jconrel.2021.02.008_bb0280","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41565-020-0679-4","article-title":"Programmable multistage drug delivery to lymph nodes","volume":"15","author":"Schudel","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"13","key":"10.1016\/j.jconrel.2021.02.008_bb0285","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1073\/pnas.1812800116","article-title":"Regulation of T cell expansion by antigen presentation dynamics","volume":"116","author":"Mayer","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2021.02.008_bb0290","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2021.02.008_bb0295","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.4049\/jimmunol.164.6.2890","article-title":"A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells","volume":"164","author":"Blanas","year":"2000","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2021.02.008_bb0300","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.4049\/jimmunol.164.9.4551","article-title":"Antigen-experienced CD4 T cells display a reduced capacity for clonal expansion in vivo that is imposed by factors present in the immune host","volume":"164","author":"Merica","year":"2000","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2021.02.008_bb0305","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.4049\/jimmunol.162.9.5212","article-title":"Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity","volume":"162","author":"Gudmundsdottir","year":"1999","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2021.02.008_bb0310","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1084\/jem.194.7.893","article-title":"Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells","volume":"194","author":"Doyle","year":"2001","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2021.02.008_bb0315","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.4049\/jimmunol.168.4.1528","article-title":"Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses","volume":"168","author":"Foulds","year":"2002","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2021.02.008_bb0320","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2249.2002.01777.x","article-title":"Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs","volume":"128","author":"Strauss","year":"2002","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2021.02.008_bb0325","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2567.2002.01427.x","article-title":"T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division","volume":"106","author":"Smith","year":"2002","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.jconrel.2021.02.008_bb0330","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1271\/bbb.80252","article-title":"Absorption, migration and kinetics in peripheral blood of orally administered ovalbumin in a mouse model","volume":"72","author":"Matsubara","year":"2008","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"2","key":"10.1016\/j.jconrel.2021.02.008_bb0335","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-3083.2006.01884.x","article-title":"Digestion, absorption and tissue distribution of ovalbumin and palmitoyl-ovalbumin: impact on immune responses triggered by orally administered antigens","volume":"65","author":"Oliveira","year":"2007","journal-title":"Scand. J. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:01:32Z","timestamp":1759161692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921000717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":67,"alternative-id":["S0168365921000717"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.02.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted delivery of mycophenolic acid to the mesenteric lymph node using a triglyceride mimetic prodrug approach enhances gut-specific immunomodulation in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}